A-Alpha Bio
A-Alpha Bio develops biotechnology platforms that use synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Its AlphaSeq platform enables rapid, quantitative measurement of millions of protein binding affinities, while AlphaBind predicts binding strength from sequence using a large protein interaction database. The company partners with pharmaceutical organizations and runs in-house therapeutic programs to support the discovery and development of novel medicines.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2017
- Type
- Corporation Seattle business license
- Employees
- 50
- Registered name
- A Alpha Bio Inc Seattle business license
- Stage
- Series A
- Members see funding amounts. .
- Founders
- David Younger, PhD, Randolph Lopez, PhD
Is this your organization? Claim it
Saray Covey announces Harell Data early-access platform connecting AI modelers with proprietary datasets from A-Alpha Bio and Adaptive Biotechnologies
Harell Data launched an early-access platform to connect AI modelers with proprietary biotech datasets so data owners and model builders can earn from training runs and model usage; initial partners include A-Alpha Bio and Adaptive Biotechnologies. The announcement links to a GeekWire article and was posted by Saray Covey.
Harell Data founded by Harlan Robins raises $15M to let data owners securely monetize AI training
Harlan Robins, co-founder and former CSO of Adaptive Biotechnologies, launched Harell Data with $15 million in funding to let proprietary data owners securely host datasets for AI model training and receive direct revenue shares instead of waiting for downstream royalties.
Harell Data Raises $15M to Reward Data Generators and Speed AI Drug Discovery, Founder Harlan Robins Launches New Cloud Service
Harell Data, founded by Harlan Robins, raised $15 million to build a cloud platform that better rewards data generators and accelerates AI-driven drug discovery by hosting proprietary, well-curated datasets and secure GPU compute. The service partners with CoreWeave and initial data contributors like A-Alpha Bio to provide datasets for model builders while creating revenue-sharing incentives for those who produce the data.
See all 40 news stories about A-Alpha Bio.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
David Younger Executive Officer, Director, Chief Executive Officer & Co-Founder
-
Randolph Lopez Chief Technology Officer & Co-Founder